The primary objective of this AREA proposal is to better understand how the Wilms' tumor suppressor gene (WT1) suppresses growth of LNCaP prostate cancer cells in vivo. Using cDNA microarrays, we observed that vascular endothelial growth factor, VEGF, was suppressed in the WT1 transfected LNCaP tumor cells (WT1-LNCaP) cells. Our hypothesis is that WT1 represses hormone induced VEGF transcription. This work is important because it will contribute to the understanding of 1) regulation of VEGF and 2) WT1 mediated tumor growth suppression. The long-term goal of this study will be to identify novel mechanisms of prostate tumor cell growth suppression and new approaches towards inhibition of angiogenesis. Additionally, this study provides a learning opportunity in the fundamentals of gene regulation for undergraduate students at Kent State University. We propose to: 1) use reporter assays to determine whether WT1 represses VEGF transcription in hormone treated cells and to disrupt that repression using WT1 targeted short inhibitory RNA (siRNA) 2) use EMSA and chromatin immunoprecipitation to determine whether WT1 repression of VEGF expression is mediated through DNA binding and 3) use immunohistochemistry of mouse tumor tissue sections to determine whether WT1 expression is inversely related to VEGF and angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15CA113360-01
Application #
6898658
Study Section
Special Emphasis Panel (ZRG1-F09 (20))
Program Officer
Tricoli, James
Project Start
2005-05-01
Project End
2009-04-30
Budget Start
2005-05-01
Budget End
2009-04-30
Support Year
1
Fiscal Year
2005
Total Cost
$208,426
Indirect Cost
Name
Kent State University at Kent
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
041071101
City
Kent
State
OH
Country
United States
Zip Code
44242
Perez-Soler, Roman; Zou, Yiyu; Li, Tianhong et al. (2011) The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab. Clin Cancer Res 17:6766-77
Hanson, Julie; Gorman, Jacquelyn; Reese, Jennifer et al. (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12:2279-90
Hanson, Julie; Reese, Jennifer; Gorman, Jacquelyn et al. (2007) Hormone treatment enhances WT1 activation of Renilla luciferase constructs in LNCaP cells. Front Biosci 12:1387-94
Cash, Jennifer; Korchnak, Amanda; Gorman, Jacquelyn et al. (2007) VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells. Oncol Rep 17:1413-9